bioRxiv · 10.1101/2024.08.29.610379
Analogues of the anti-malaria drug mefloquine have broad spectrum antifungal activity and are efficacious in a model of disseminated Candida auris infection.
Abstract
Only three classes of antifungal drugs are currently in clinical use. Here, we report that derivatives of the malarial drug mefloquine have broad spectrum antifungal activity including difficult to treat molds and endemic fungi. Pharmacokinetic and efficacy studies of NSC-4377 indicate it penetrates the central nervous system and is active against Candida auris in vivo. These data strongly support the further development of mefloquine analogs as a potentially new class of antifungal molecules.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Guin, S., montoya, m., wang, X., Zarnowski, R., Andes, D. R., Meyers, M. J., Williams, N., Krysan, D. J.. 2024-08-30. Analogues of the anti-malaria drug mefloquine have broad spectrum antifungal activity and are efficacious in a model of disseminated Candida auris infection.. https://doi.org/10.1101/2024.08.29.610379
Cite the original work for its findings. Save a collection to share your selection of sources.